So in controlling blood sugar and reducing fat in the body, GLP-1 medications can make ovulation more predictable, which means that people then may get pregnant sooner than expected, says Kimberly Sampson-Paine, MD, a double board-certified ob-gyn and obesity medicine specialist at Southwestern Vermont Medical Center
Survodutide Dosing The SYNCHRONIZE Phase 3 trials use a modified escalation protocol designed to improve tolerability compared to Phase 2: Starting dose: Low dose with gradual increases Escalation: Extended titration period with flexibility Target doses: 3.6mg or 6.0mg weekly (SYNCHRONIZE-1) Pause option: Ability to temporarily stop dosing for GI symptoms Time to maintenance: Extended to reduce side effects The inclusion of a pause option in Survodutide trials reflects lessons learned from Phase 2 about the importance of allowing patient-directed tolerance management
In contrast, drugs modeled after gastrointestinal hormones, such as glucagon-like peptide-1 (GLP-1), have been shown to exhibit fewer side effects while demonstrating high efficacy in obesity treatment
Since there is currently no specific antidote generally available to reverse bleeding in patients taking Xarelto, activated charcoal may be used to reduce absorption of the drug
24 Similarly, it is prudent to prescribe ursodeoxycholic acid during the first year of GLP-1 receptor agonist therapy to prevent gallstone formation
Remarkably, half of the participants managed to shed 15% of their body weight, and nearly one-third lost 20%